These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4336881)

  • 41. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 42. Serologic and structural studies of mouse mammary tumor virus.
    Nowinski RC; Sarkar NH
    J Natl Cancer Inst; 1972 Apr; 48(4):1169-76. PubMed ID: 4336880
    [No Abstract]   [Full Text] [Related]  

  • 43. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
    Lopez DM; Parks WP; Silverman MA; Distasio JA
    J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 46. Life cycle of the murine mammary tumor virus, and a comparison with similar forms reported in human mammary carcinomas.
    Dolowy WC
    Tex Rep Biol Med; 1973; 31(4):745-53. PubMed ID: 4362650
    [No Abstract]   [Full Text] [Related]  

  • 47. Sites of synthesis of murine RNA tumor virus (oncornavirus) group-specific antigens.
    Pattengale PK; Ikeda H; Thorbecke GJ
    Cancer Res; 1974 Apr; 34(4):810-7. PubMed ID: 4360841
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunologic cross reactions between virus producing and non-virus producing murine mammary carcinoma].
    Zotter S; Kemmer C; Müller M; Micheel B
    Arch Geschwulstforsch; 1972; 40(1):23-34. PubMed ID: 4347235
    [No Abstract]   [Full Text] [Related]  

  • 49. Circulating immune complexes, antigens, and antibodies related to the murine mammary tumor virus in C3H mice.
    Dong ZW; Witkin SS; Fernandes G; Sarkar NH; Good RA; Day NK
    J Immunol; 1982 Aug; 129(2):872-6. PubMed ID: 6282972
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular and morphological evidence for type B retrovirus (oncornavirus) expression in human mammary carcinoma. An overview using scanning electron microscopy, immunoperoxidase staining, and transmission electron microscopy.
    Mitchell WM; Halter SA; Schuffman SS; Hartmann WH
    Scan Electron Microsc; 1980; (3):1-12. PubMed ID: 6251536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of exogenous interferon treatment on mouse mammary tumors.
    Came PE; Moore DH
    J Natl Cancer Inst; 1972 Apr; 48(4):1151-4. PubMed ID: 4336879
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An antigen in human breast cancer sera related to the murine mammary tumour virus.
    Müller M; Grossman H
    Nat New Biol; 1972 May; 237(73):116-7. PubMed ID: 4338143
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphocyte inhibition by mammary tumor virus in patients with breast cancer.
    Moulton A; Gerfo PL; Suciu-Foca N; Silverstein G
    J Surg Res; 1974 Jun; 16(6):592-8. PubMed ID: 4366357
    [No Abstract]   [Full Text] [Related]  

  • 55. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of transient immunosuppression on host response to neonatally introduced oncogenic virus.
    Blair PB
    Cancer Res; 1972 Feb; 32(2):356-9. PubMed ID: 4333498
    [No Abstract]   [Full Text] [Related]  

  • 57. Mouse mammary tumor virus-like viral infection and human breast cancer.
    Holland JF; Pogo BG
    Clin Cancer Res; 2004 Sep; 10(17):5647-9. PubMed ID: 15355888
    [No Abstract]   [Full Text] [Related]  

  • 58. Breast cancer: etiology and possible prevention.
    Moore DH; Charney J
    Am Sci; 1975; 63(2):160-8. PubMed ID: 163605
    [No Abstract]   [Full Text] [Related]  

  • 59. Breast cancer and T-cell-mediated immunity to proteins of the mouse mammary tumour virus (MMTV).
    de Ricqlès D; Olomucki A; Gosselin F; Lidereau R
    Eur Cytokine Netw; 1993; 4(2):153-60. PubMed ID: 8391340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demonstration by the antiglobulin consumption test with murine antisera of common antigens in tissues infected with the mammary tumor virus from different mouse strains.
    Holmes EC; Morton DL
    J Natl Cancer Inst; 1971 Feb; 46(2):253-60. PubMed ID: 4107242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.